Tori-palimab, identified chemically as compound 1924598-82-2, is a humanized single antibody designed to target PD1, an immunologic checkpoint molecule. Its mode of operation involves inhibiting the binding between https://toripalimab-in-vitro-ass915087.activoblog.com/profile